Published on 12/02/2010
Scientists at the University of Dundee have identified new genetic 'hotspots' for bowel
cancer, offering doctors a way of tailoring treatment to benefit individual patients' medical needs.
According to the research, this discovery could help experts match therapies to as many as 3,000 more bowel
cancer sufferers a year.
Dr Rob Glynne Jones, expert advisor at Bowel
Cancer UK, said: "The problem we have is that the cancers are very heterogeneous (contain multiple variations).
"This is another step in the direction of being able to be very specific about the individual's chance of responding to the treatment, and in making these expensive drugs more cost effective."
The findings follow recent national figures from
Cancer Research, which show that over 37,500 people are diagnosed with bowel
cancer each year in the UK - the equivalent to more than 100 people every day.
More than eight in ten bowel
cancer cases occur in people aged 60 and over, statistics show.
© ActiveQuote Health Ltd. 2010
Categories: Medical
Related Health Insurance News Articles
08/02/2012Hospital superbug C. difficle source is unclear, say scientistsScientists cannot explain how 75 per cent of people catch the superbug C. difficile, after a study showed that only a quarter of infections in one hospital system were traced to contact with a suffering...
09/02/2012Coronary heart disease gene is passed from father to sonUp to one in five men is carrying a gene from their father that increases their risk of coronary heart disease by 50 per cent. A study has found that men can inherit a form of heart disease from their father...
09/02/2012Fasting paired with chemotherapy significantly slows the growth of cancer cellsAn interesting new study indicates that starvation paired with chemotherapy can significantly reduce the growth of cancer cells, matching or improving the effects of chemotherapy alone. Scientists at the...
10/02/2012Scientists reverse effects of Alzheimer's in mice using skin cancer drug bexaroteneScientists have reversed the effects of Alzheimer’s disease in mice using an already licensed skin cancer drug. Destructive plaques commonly found in the brains of Alzheimer’s patients were broken...
10/02/2012Chemotherapy during pregnancy does not harm the unborn childChemotherapy during pregnancy does not necessarily harm the unborn child, according to a ground-breaking new report. The study, published in the Lancet Oncology journal, shows that children born to women...